Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Endocrine involvement in immunotherapy]

E Tartour1, M Schlumberger, T Dorval

  • 1Laboratoire d'Immunologie Clinique et INSERM U 255, Institut Curie, Paris.

Annales D'Endocrinologie
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characteristics, management, and outcomes of patients with VIPoma-A retrospective analysis of the ENETS database.

Journal of neuroendocrinology·2026
Same author

Streptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): a randomized clinical trial.

ESMO open·2025
Same author

Time-domain braiding of anyons.

Science (New York, N.Y.)·2025
Same author

Proof of concept and design of an externally controlled trial for patients with gastro-enteropancreatic neuroendocrine carcinomas based on the randomized phase II BEVANEC trial.

European journal of cancer (Oxford, England : 1990)·2025
Same author

Time-resolved sensing of electromagnetic fields with single-electron interferometry.

Nature nanotechnology·2025
Same author

Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

ESMO open·2024
Same journal

[18F]F-DOPA and [18F]F-FDG PET/CT for staging advanced medullary thyroid cancer.

Annales d'endocrinologie·2026
Same journal

Corrigendum to 'Pink adipose tissue: A paradigm of adipose tissue plasticity' [Ann. Endocrinol. 85 (2004) 248-51].

Annales d'endocrinologie·2026
Same journal

Intraoperative location of parathyroid glands during total thyroidectomy: a systematic review of the literature according to the PRISMA method.

Annales d'endocrinologie·2026
Same journal

Clinical and genetic diagnosis of PHP1A associated with hypogonadism in a young male: A case report.

Annales d'endocrinologie·2026
Same journal

Autoimmune features in acquired generalized lipodystrophy and anti-perilipin 1 antibodies: A case report.

Annales d'endocrinologie·2026
Same journal

The diagnostic challenge of occult glucocorticoid exposure causing Cushing's syndrome.

Annales d'endocrinologie·2026
See all related articles

Immunostimulating cytokines like Interleukin 2 (IL2) and Interferon alpha (IFN alpha) can cause thyroid dysfunction and alter corticosteroid regulation. These endocrine side effects highlight the immune system

Area of Science:

  • Endocrinology
  • Immunology
  • Oncology

Background:

  • Cytokine therapy, including Interleukin 2 (IL2) and Interferon alpha (IFN alpha), is used for its immunostimulating properties.
  • Clinical use of these cytokines has been associated with thyroid dysfunction and abnormalities in corticosteroid regulation.
  • Observed thyroid dysfunctions include hypothyroidism, hyperthyroidism, and the development of auto-antibodies.

Framework:

  • The study investigates the endocrine side effects of cytokine therapy.
  • It examines the impact of IL2 and IFN alpha on thyroid function and corticosteroid regulation.
  • Potential mechanisms, including autoimmune responses and direct cytokine effects, are explored.

Implementation:

  • Patients receiving IL2 or IFN alpha therapy exhibited thyroid dysfunction in 20-40% of cases.

Related Experiment Videos

  • IL2 administration led to hypothyroidism, sometimes with anti-thyroglobulin and anti-thyroid microsomal antibodies, resembling Hashimoto's thyroiditis.
  • IFN alpha administration was linked to hypothyroidism and hyperthyroidism with anti-TSH receptor antibodies.

    • Implications:

    • Cytokine-induced endocrine effects, such as altered ACTH, cortisol, and testosterone levels, may influence treatment efficacy.
    • The findings underscore the bidirectional communication between the immune and endocrine systems.
    • Understanding these interactions is crucial for managing patients undergoing cytokine therapy.